These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37663966)

  • 41. Clinical Significance of Paraspinal Muscle Parameters as a prognostic factor for survival in Gastric Cancer Patients who underwent Curative Surgical Resection.
    Eo W; Kwon J; An S; Lee S; Kim S; Nam D; Han GY; Choi SI; Chung HY
    J Cancer; 2020; 11(19):5792-5801. PubMed ID: 32913472
    [No Abstract]   [Full Text] [Related]  

  • 42. Frequency and prognostic impact of cachexia during drug treatment for unresectable advanced gastric cancer patients.
    Namikawa T; Marui A; Yokota K; Fujieda Y; Munekage M; Uemura S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
    Surg Today; 2022 Nov; 52(11):1560-1567. PubMed ID: 35322296
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The combination of body composition conditions and systemic inflammatory markers has prognostic value for patients with gastric cancer treated with adjuvant chemoradiotherapy.
    Li Y; Wang WB; Yang L; Wang QY; Dai J; Xia L; Peng J; Zhou FX; Wei YC; Shi HP
    Nutrition; 2022 Jan; 93():111464. PubMed ID: 34678715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extracellular water to total body water ratio may mediate the association between phase angle and mortality in patients with cancer cachexia: A single-center, retrospective study.
    Katsura N; Yamashita M; Ishihara T
    Clin Nutr ESPEN; 2021 Dec; 46():193-199. PubMed ID: 34857195
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic nutritional index as a predictor of survival in resectable gastric cancer patients with normal preoperative serum carcinoembryonic antigen levels: a propensity score matching analysis.
    Hirahara N; Tajima Y; Fujii Y; Kaji S; Yamamoto T; Hyakudomi R; Taniura T; Kawabata Y
    BMC Cancer; 2018 Mar; 18(1):285. PubMed ID: 29534689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical Effects of the Neutrophil-to-Lymphocyte Ratio/Serum Albumin Ratio in Patients with Gastric Cancer after Gastrectomy.
    Onuma S; Hashimoto I; Suematsu H; Nagasawa S; Kanematsu K; Aoyama T; Yamada T; Rino Y; Ogata T; Oshima T
    J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of pretherapeutic neutrophil-to-lymphocyte ratio, serum albumin, body-mass index, and advanced lung cancer inflammation index on clinical outcome in sinonasal squamous cell carcinoma.
    Brkic FF; Kadletz L; Jank B; Mayer C; Heiduschka G; Brunner M
    J Craniomaxillofac Surg; 2020 Jan; 48(1):33-37. PubMed ID: 31810849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection.
    Kuroda D; Sawayama H; Kurashige J; Iwatsuki M; Eto T; Tokunaga R; Kitano Y; Yamamura K; Ouchi M; Nakamura K; Baba Y; Sakamoto Y; Yamashita Y; Yoshida N; Chikamoto A; Baba H
    Gastric Cancer; 2018 Mar; 21(2):204-212. PubMed ID: 28656485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the prognostic impact and combination of preoperative inflammation-based and/or nutritional markers in patients with stage II gastric cancer.
    Toyokawa T; Muguruma K; Tamura T; Sakurai K; Amano R; Kubo N; Tanaka H; Yashiro M; Hirakawa K; Ohira M
    Oncotarget; 2018 Jun; 9(50):29351-29364. PubMed ID: 30034622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Nutritional status predicts clinical outcomes in patients with gastric cancer undergoing radical gastrectomy].
    Zhu XS; Zhao Y; Ma FY; Xuan L; Wu SK
    Zhonghua Yi Xue Za Zhi; 2021 Feb; 101(6):421-428. PubMed ID: 33611892
    [No Abstract]   [Full Text] [Related]  

  • 51. Prognostic value of GLIM-defined malnutrition in combination with hand-grip strength or gait speed for the prediction of postoperative outcomes in gastric cancer patients with cachexia.
    Li ZZ; Yan XL; Zhang Z; Chen JL; Li JY; Bao JX; Ru JT; Wang JX; Chen XL; Shen X; Huang DD
    BMC Cancer; 2024 Feb; 24(1):253. PubMed ID: 38395798
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Using the preoperative prognostic nutritional index as a predictive factor for non-cancer-related death in post-curative resection gastric cancer patients: a retrospective cohort study.
    Takechi H; Fujikuni N; Tanabe K; Hattori M; Amano H; Noriyuki T; Nakahara M
    BMC Gastroenterol; 2020 Aug; 20(1):256. PubMed ID: 32758144
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
    Toyokawa T; Muguruma K; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Yashiro M; Ohira M
    BMC Cancer; 2020 Jun; 20(1):517. PubMed ID: 32493247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic inflammation and insulin resistance-related indicator predicts poor outcome in patients with cancer cachexia.
    Ruan GT; Deng L; Xie HL; Shi JY; Liu XY; Zheng X; Chen Y; Lin SQ; Zhang HY; Liu CA; Ge YZ; Song MM; Hu CL; Zhang XW; Yang M; Hu W; Cong MH; Zhu LC; Wang KH; Shi HP
    Cancer Metab; 2024 Jan; 12(1):3. PubMed ID: 38273418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of sarcopenic obesity and prediction of long-term survival in patients with gastric cancer using preoperative computed tomography and machine learning.
    Kim J; Han SH; Kim HI
    J Surg Oncol; 2021 Dec; 124(8):1347-1355. PubMed ID: 34490899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel prognostic indicator combining inflammatory indicators and tumor markers for gastric cancer.
    Yu L; Jiang R; Chen W; Liu Y; Wang G; Gong X; Wang Y
    World J Surg Oncol; 2023 Feb; 21(1):50. PubMed ID: 36803398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cachexia Versus Sarcopenia in Clinical Characteristics and Prognostic Value After Radical Gastrectomy for Gastric Cancer: A Large-Scale Prospective Study.
    Zhuang CL; Dong QT; Shi HP; Zhang FM; Luo X; Wang WB; Yu Z; Chen XL; Wang SL
    Ann Surg Oncol; 2022 Apr; 29(4):2348-2358. PubMed ID: 34797480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Soluble PD‑L1 reflects cachexia status in patients with gastric cancer and is an independent prognostic marker for relapse‑free survival after radical surgery.
    Matsumoto Y; Sasaki T; Kano M; Shiraishi T; Suito H; Murakami K; Toyozumi T; Otsuka R; Kinoshita K; Iida S; Morishita H; Nishioka Y; Hayano K; Kurata Y; Hayashi H; Matsubara H
    Mol Clin Oncol; 2023 May; 18(5):39. PubMed ID: 37035474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical Significance of the Prognostic Nutritional Index for Predicting Short- and Long-Term Surgical Outcomes After Gastrectomy: A Retrospective Analysis of 7781 Gastric Cancer Patients.
    Lee JY; Kim HI; Kim YN; Hong JH; Alshomimi S; An JY; Cheong JH; Hyung WJ; Noh SH; Kim CB
    Medicine (Baltimore); 2016 May; 95(18):e3539. PubMed ID: 27149460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel immunological and nutritional-based prognostic index for gastric cancer.
    Sun KY; Xu JB; Chen SL; Yuan YJ; Wu H; Peng JJ; Chen CQ; Guo P; Hao YT; He YL
    World J Gastroenterol; 2015 May; 21(19):5961-71. PubMed ID: 26019461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.